How a Missing Clotting Protein Leads to Hemophilia

Hemophilia is caused by a shortage or malfunction of a specific blood clotting protein. Your body makes 13 different clotting factors that work in sequence to stop bleeding — hemophilia disrupts this chain by removing or breaking one link. In hemophilia A, the missing protein is clotting factor VIII. In hemophilia B, it is clotting factor IX. Without enough of these proteins, your blood cannot form stable clots, so bleeding lasts longer than normal and can happen from minor injuries or sometimes without any injury at all.

The severity of hemophilia depends on how much of the clotting factor your body produces. Someone with severe hemophilia has less than 1% of the normal amount. Moderate hemophilia means 1% to 5% of normal levels. Mild hemophilia means 5% to 40% of normal levels. A person with mild hemophilia might bleed only after surgery or a significant injury, while someone with severe hemophilia can bleed into joints or muscles spontaneously, with no clear cause.

Key Takeaways

  • Hemophilia A and B are caused by inherited mutations in genes that tell your body how to make clotting factors VIII and IX.
  • Hemophilia A is far more common than hemophilia B, accounting for about 80% of all hemophilia cases.
  • The genes for hemophilia are located on the X chromosome, which is why hemophilia affects males much more often than females.
  • A person can inherit hemophilia from a parent, or a new mutation can occur spontaneously during the formation of a parent's egg or sperm.
  • The amount of clotting factor your body makes determines severity — severe, moderate, or mild — and how often bleeding episodes occur.

The Genetic Mutation Behind Hemophilia A and B

Hemophilia is an inherited genetic condition, meaning it is caused by a change in DNA that is passed down through families. The gene that controls production of clotting factor VIII (in hemophilia A) or clotting factor IX (in hemophilia B) contains instructions for making these proteins. When a mutation alters this gene, the instructions become garbled or incomplete. Your body either makes too little of the clotting factor, makes a version that does not work properly, or makes none at all.

These mutations can be large deletions that remove whole sections of the gene, small point mutations that change a single letter of the genetic code, or inversions where a piece of the gene flips backward. Different mutations cause different levels of severity. Some mutations completely shut down protein production, causing severe hemophilia. Others allow partial production, resulting in mild or moderate hemophilia. Researchers have identified thousands of different mutations that cause hemophilia, and the specific mutation a person carries helps predict how severe their bleeding will be.

Why Hemophilia Affects Males Far More Often Than Females

The genes for clotting factors VIII and IX sit on the X chromosome, one of the two sex chromosomes. Males have one X chromosome and one Y chromosome (XY), while females have two X chromosomes (XX). This difference in chromosome number explains why hemophilia is much more common in males.

A male with a mutation on his single X chromosome will have hemophilia, because he has no second X chromosome to provide a working copy of the gene. A female would need mutations on both of her X chromosomes to have hemophilia — a much rarer event. However, a female with a mutation on one X chromosome is a carrier. She has one working copy and one mutated copy, so she usually produces enough clotting factor to avoid severe bleeding. Some carrier females do experience bleeding symptoms, particularly if one X chromosome is preferentially active in their cells, but most carriers have few or no symptoms.

Because of this pattern, hemophilia A and B appear in family trees in a recognizable way: affected males, carrier females who pass the condition to their sons, and unaffected males whose daughters are all carriers.

Inherited Versus New Mutations

About 70% of people with hemophilia inherited the mutation from a parent — usually from a carrier mother. The other 30% have hemophilia because of a de novo mutation, a new genetic change that occurred spontaneously in the egg or sperm that created them. A de novo mutation means neither parent carries the mutation in their own cells, so there is no family history of hemophilia.

De novo mutations happen randomly during the process of egg or sperm formation. They are not caused by anything the parents did or did not do during pregnancy. A person born with a de novo mutation can pass hemophilia to their children, just as someone who inherited it can. If a male with hemophilia has children, all of his daughters will be carriers (because they receive his X chromosome), but none of his sons will have hemophilia (because sons receive the Y chromosome from their father).

Why Hemophilia A Is More Common Than Hemophilia B

Hemophilia A accounts for roughly 80% of all hemophilia cases, while hemophilia B makes up about 20%. This difference is not fully understood, but it reflects the natural variation in how often mutations occur in different genes. The gene for clotting factor VIII is larger than the gene for clotting factor IX, and larger genes are statistically more likely to accumulate mutations simply because there is more DNA to mutate.

Additionally, some mutations in the factor VIII gene may be more likely to survive and be passed to the next generation, while others may be lethal to the developing fetus. The specific biology of each gene influences how often mutations arise and how often they persist in the population. The result is that a person newly diagnosed with hemophilia is much more likely to have hemophilia A than hemophilia B.

How Clotting Factors Normally Work

To understand why a missing clotting factor causes bleeding problems, it helps to know what these proteins do. When you cut yourself, platelets (small blood cells) rush to the wound and stick together to form a plug. But a platelet plug alone is not strong enough to stop serious bleeding. Your body needs to reinforce it with fibrin, a tough protein that forms a mesh.

Clotting factors are enzymes that activate each other in a cascade — factor VIII activates factor X, which activates factor II, and so on — until the final factor converts fibrinogen into fibrin. This cascade is fast and powerful, but it requires every step to work. If factor VIII or factor IX is missing or broken, the cascade stalls. Fibrin never forms, the platelet plug remains weak, and bleeding continues. The lower the level of the missing factor, the longer it takes for the cascade to work, and the longer bleeding lasts.

Severity Levels and What They Mean for Bleeding Risk

The amount of clotting factor in your blood is measured as a percentage of normal. Someone with normal clotting function has 100% of the factor. The three severity categories are defined by these percentages, and they predict how often and how easily bleeding will occur.

Severe hemophilia (less than 1% factor) causes spontaneous bleeding — bleeding that happens without injury. A person with severe hemophilia may wake up with bleeding in a joint or muscle, or bleed from the gums or nose without any trauma. Bleeding episodes can be life-threatening if they occur in the brain, throat, or abdomen. Moderate hemophilia (1% to 5% factor) causes bleeding with minor injuries or after surgery, and occasionally spontaneous bleeding. Mild hemophilia (5% to 40% factor) typically causes bleeding only after significant injury, surgery, or dental work. A person with mild hemophilia might not know they have the condition until they have a surgery or accident and bleed unusually long.

Frequently Asked Questions

Can hemophilia develop later in life if someone was born without it?

No. Hemophilia is present from birth because it is caused by a genetic mutation you are born with. However, a condition called acquired hemophilia can develop in adults when the immune system produces antibodies that attack clotting factors. This is rare and is a different condition from inherited hemophilia.

If both parents have hemophilia or are carriers, what are the chances their child will have it?

The odds depend on whether each parent is affected or a carrier, and on the child's sex. If the mother is a carrier and the father is unaffected, each son has a 50% chance of hemophilia and each daughter has a 50% chance of being a carrier. If the mother is affected and the father is unaffected, all daughters will be carriers and all sons will have hemophilia. A genetic counselor can calculate exact odds for your specific situation.

Does the severity of hemophilia change over time?

The underlying genetic mutation does not change, so the amount of clotting factor your body naturally produces stays roughly the same throughout life. However, certain illnesses, medications, or stress can temporarily affect clotting factor levels. Treatment with clotting factor replacement can raise levels above what your body produces on its own, but once treatment stops, levels return to baseline.

Can a female with hemophilia pass it to her children?

Yes. A female with hemophilia has mutations on both X chromosomes. All of her daughters will inherit at least one mutated X chromosome and will be carriers or affected. All of her sons will inherit one mutated X chromosome and will have hemophilia. This is why hemophilia in females, though rare, is significant for family planning.